nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC7A11—forelimb zeugopod—pharynx cancer	0.135	0.24	CbGeAlD
Sulfasalazine—CHUK—EBV LMP1 signaling—PDLIM7—pharynx cancer	0.045	0.103	CbGpPWpGaD
Sulfasalazine—IKBKB—EBV LMP1 signaling—PDLIM7—pharynx cancer	0.0408	0.0934	CbGpPWpGaD
Sulfasalazine—SLC7A11—tongue—pharynx cancer	0.0363	0.0644	CbGeAlD
Sulfasalazine—TBXAS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0309	0.0707	CbGpPWpGaD
Sulfasalazine—PLA2G1B—mouth—pharynx cancer	0.0279	0.0495	CbGeAlD
Sulfasalazine—TBXAS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0271	0.062	CbGpPWpGaD
Sulfasalazine—SLC7A11—mouth—pharynx cancer	0.0244	0.0433	CbGeAlD
Sulfasalazine—ACAT1—Amino acid and derivative metabolism—CNDP2—pharynx cancer	0.0223	0.051	CbGpPWpGaD
Sulfasalazine—TBXAS1—Biological oxidations—CNDP2—pharynx cancer	0.0181	0.0415	CbGpPWpGaD
Sulfasalazine—CHUK—epithelium—pharynx cancer	0.0172	0.0306	CbGeAlD
Sulfasalazine—TBXAS1—Biological oxidations—ADH7—pharynx cancer	0.0164	0.0375	CbGpPWpGaD
Sulfasalazine—PLA2G1B—epithelium—pharynx cancer	0.0162	0.0288	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—pharynx cancer	0.0162	0.0287	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—pharynx cancer	0.0149	0.0265	CbGeAlD
Sulfasalazine—TBXAS1—Biological oxidations—ADH1B—pharynx cancer	0.0144	0.0329	CbGpPWpGaD
Sulfasalazine—ACAT1—head—pharynx cancer	0.0144	0.0255	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—pharynx cancer	0.0133	0.0236	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—pharynx cancer	0.0133	0.0236	CbGeAlD
Sulfasalazine—SLC7A11—NRF2 pathway—ADH7—pharynx cancer	0.012	0.0276	CbGpPWpGaD
Sulfasalazine—SLC46A1—spinal cord—pharynx cancer	0.012	0.0214	CbGeAlD
Sulfasalazine—TBXAS1—head—pharynx cancer	0.012	0.0213	CbGeAlD
Sulfasalazine—PPARG—neck—pharynx cancer	0.0107	0.019	CbGeAlD
Sulfasalazine—CHUK—head—pharynx cancer	0.0107	0.019	CbGeAlD
Sulfasalazine—SLC46A1—head—pharynx cancer	0.0107	0.019	CbGeAlD
Sulfasalazine—PLA2G1B—head—pharynx cancer	0.0101	0.0179	CbGeAlD
Sulfasalazine—ACAT1—lymph node—pharynx cancer	0.0101	0.0179	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—pharynx cancer	0.00992	0.0176	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—pharynx cancer	0.00903	0.016	CbGeAlD
Sulfasalazine—SLC7A11—head—pharynx cancer	0.00881	0.0156	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—pharynx cancer	0.00841	0.0149	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—pharynx cancer	0.00749	0.0133	CbGeAlD
Sulfasalazine—CHUK—lymph node—pharynx cancer	0.00749	0.0133	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—pharynx cancer	0.00748	0.0133	CbGeAlD
Sulfasalazine—PPARG—epithelium—pharynx cancer	0.00729	0.0129	CbGeAlD
Sulfasalazine—IKBKB—head—pharynx cancer	0.00727	0.0129	CbGeAlD
Sulfasalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00692	0.0159	CbGpPWpGaD
Sulfasalazine—PTGS2—mouth—pharynx cancer	0.00641	0.0114	CbGeAlD
Sulfasalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00607	0.0139	CbGpPWpGaD
Sulfasalazine—ALOX5—head—pharynx cancer	0.00603	0.0107	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—pharynx cancer	0.00562	0.00997	CbGeAlD
Sulfasalazine—ABCG2—parotid gland—pharynx cancer	0.0056	0.00993	CbGeAlD
Sulfasalazine—ABCG2—saliva-secreting gland—pharynx cancer	0.00536	0.00951	CbGeAlD
Sulfasalazine—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00516	0.0118	CbGpPWpGaD
Sulfasalazine—IKBKB—lymph node—pharynx cancer	0.00509	0.00904	CbGeAlD
Sulfasalazine—ABCC2—NRF2 pathway—ADH7—pharynx cancer	0.00502	0.0115	CbGpPWpGaD
Sulfasalazine—CHUK—BCR signaling pathway—CD79A—pharynx cancer	0.00481	0.011	CbGpPWpGaD
Sulfasalazine—PPARG—head—pharynx cancer	0.00453	0.00804	CbGeAlD
Sulfasalazine—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00453	0.0104	CbGpPWpGaD
Sulfasalazine—IKBKB—BCR signaling pathway—CD79A—pharynx cancer	0.00436	0.00999	CbGpPWpGaD
Sulfasalazine—ALOX5—lymph node—pharynx cancer	0.00422	0.00749	CbGeAlD
Sulfasalazine—ACAT1—Metabolism—CNDP2—pharynx cancer	0.00409	0.00937	CbGpPWpGaD
Sulfasalazine—PTGS1—Biological oxidations—CNDP2—pharynx cancer	0.00407	0.00931	CbGpPWpGaD
Sulfasalazine—PTGS1—epithelium—pharynx cancer	0.0039	0.00692	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—TP53—pharynx cancer	0.00387	0.00887	CbGpPWpGaD
Sulfasalazine—PTGS2—epithelium—pharynx cancer	0.00373	0.00662	CbGeAlD
Sulfasalazine—ACAT1—Metabolism—ADH7—pharynx cancer	0.0037	0.00847	CbGpPWpGaD
Sulfasalazine—PTGS1—Biological oxidations—ADH7—pharynx cancer	0.00368	0.00842	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00358	0.00819	CbGpPWpGaD
Sulfasalazine—PTGS1—trachea—pharynx cancer	0.00345	0.00612	CbGeAlD
Sulfasalazine—PTGS2—trachea—pharynx cancer	0.0033	0.00585	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—pharynx cancer	0.00326	0.0058	CbGeAlD
Sulfasalazine—ACAT1—Metabolism—ADH1B—pharynx cancer	0.00324	0.00743	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00324	0.00743	CbGpPWpGaD
Sulfasalazine—PTGS1—Biological oxidations—ADH1B—pharynx cancer	0.00322	0.00738	CbGpPWpGaD
Sulfasalazine—PPARG—lymph node—pharynx cancer	0.00317	0.00563	CbGeAlD
Sulfasalazine—ACAT1—Metabolism—B4GALT5—pharynx cancer	0.0031	0.0071	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—CNDP2—pharynx cancer	0.0031	0.0071	CbGpPWpGaD
Sulfasalazine—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00303	0.00694	CbGpPWpGaD
Sulfasalazine—PTGS2—lymphoid tissue—pharynx cancer	0.00287	0.0051	CbGeAlD
Sulfasalazine—TBXAS1—Metabolism—ADH7—pharynx cancer	0.0028	0.00642	CbGpPWpGaD
Sulfasalazine—ABCC2—lymph node—pharynx cancer	0.00279	0.00495	CbGeAlD
Sulfasalazine—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00274	0.00628	CbGpPWpGaD
Sulfasalazine—PTGS1—spinal cord—pharynx cancer	0.00272	0.00483	CbGeAlD
Sulfasalazine—SLC46A1—Metabolism—CNDP2—pharynx cancer	0.00271	0.00621	CbGpPWpGaD
Sulfasalazine—PPARG—Wnt Signaling Pathway Netpath—CCND1—pharynx cancer	0.00261	0.00597	CbGpPWpGaD
Sulfasalazine—PTGS2—spinal cord—pharynx cancer	0.0026	0.00462	CbGeAlD
Sulfasalazine—TBXAS1—Metabolism—ADH1B—pharynx cancer	0.00246	0.00563	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—B4GALT5—pharynx cancer	0.00245	0.00562	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—ADH7—pharynx cancer	0.00245	0.00561	CbGpPWpGaD
Sulfasalazine—PTGS1—head—pharynx cancer	0.00242	0.0043	CbGeAlD
Sulfasalazine—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.0024	0.00551	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—B4GALT5—pharynx cancer	0.00235	0.00538	CbGpPWpGaD
Sulfasalazine—PTGS2—head—pharynx cancer	0.00231	0.00411	CbGeAlD
Sulfasalazine—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—pharynx cancer	0.00228	0.00521	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—CNDP2—pharynx cancer	0.00226	0.00518	CbGpPWpGaD
Sulfasalazine—PPARG—Regulation of retinoblastoma protein—CCND1—pharynx cancer	0.00215	0.00493	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—ADH1B—pharynx cancer	0.00215	0.00492	CbGpPWpGaD
Sulfasalazine—CHUK—Validated nuclear estrogen receptor alpha network—CCND1—pharynx cancer	0.00207	0.00474	CbGpPWpGaD
Sulfasalazine—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—pharynx cancer	0.00206	0.00473	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—B4GALT5—pharynx cancer	0.00205	0.0047	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—CD79A—pharynx cancer	0.00205	0.00469	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ADH7—pharynx cancer	0.00205	0.00468	CbGpPWpGaD
Sulfasalazine—ABCG2—lymph node—pharynx cancer	0.00203	0.00361	CbGeAlD
Sulfasalazine—IKBKB—B Cell Activation—CD79A—pharynx cancer	0.00186	0.00425	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—CCND1—pharynx cancer	0.00182	0.00418	CbGpPWpGaD
Sulfasalazine—ABCG2—Fluoropyrimidine Activity—TP53—pharynx cancer	0.0018	0.00412	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—ADH1B—pharynx cancer	0.00179	0.00411	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—B4GALT5—pharynx cancer	0.00171	0.00393	CbGpPWpGaD
Sulfasalazine—PTGS1—lymph node—pharynx cancer	0.00169	0.00301	CbGeAlD
Sulfasalazine—IKBKB—Leptin signaling pathway—CCND1—pharynx cancer	0.00165	0.00379	CbGpPWpGaD
Sulfasalazine—PTGS2—lymph node—pharynx cancer	0.00162	0.00288	CbGeAlD
Sulfasalazine—ALOX5—Metabolism—CNDP2—pharynx cancer	0.0016	0.00367	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—EGFR—pharynx cancer	0.00159	0.00363	CbGpPWpGaD
Sulfasalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.00157	0.00359	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ADH7—pharynx cancer	0.00145	0.00332	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—EGFR—pharynx cancer	0.00144	0.00329	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.00142	0.00325	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.0014	0.0032	CbGpPWpGaD
Sulfasalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00132	0.00301	CbGpPWpGaD
Sulfasalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00131	0.003	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.00128	0.00294	CbGpPWpGaD
Sulfasalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.00128	0.00294	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—ADH1B—pharynx cancer	0.00127	0.00291	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00125	0.00287	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—B4GALT5—pharynx cancer	0.00122	0.00278	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00119	0.00273	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.00117	0.00267	CbGpPWpGaD
Sulfasalazine—CHUK—PI-3K cascade—EGFR—pharynx cancer	0.00116	0.00265	CbGpPWpGaD
Sulfasalazine—CHUK—PI3K/AKT activation—EGFR—pharynx cancer	0.00113	0.00258	CbGpPWpGaD
Sulfasalazine—CHUK—GAB1 signalosome—EGFR—pharynx cancer	0.00112	0.00256	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TP53—pharynx cancer	0.0011	0.00251	CbGpPWpGaD
Sulfasalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00109	0.0025	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00104	0.00239	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TP53—pharynx cancer	0.000995	0.00228	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CNDP2—pharynx cancer	0.000992	0.00227	CbGpPWpGaD
Sulfasalazine—PTGS2—C-MYB transcription factor network—CCND1—pharynx cancer	0.000987	0.00226	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.000934	0.00214	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ADH7—pharynx cancer	0.000898	0.00206	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000864	0.00198	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000864	0.00198	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—B4GALT5—pharynx cancer	0.000843	0.00193	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000827	0.00189	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD79A—pharynx cancer	0.000825	0.00189	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000818	0.00187	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—EGFR—pharynx cancer	0.000814	0.00186	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ADH1B—pharynx cancer	0.000787	0.0018	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CNDP2—pharynx cancer	0.000781	0.00179	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—EGFR—pharynx cancer	0.000777	0.00178	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—EGFR—pharynx cancer	0.000773	0.00177	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—EGFR—pharynx cancer	0.000769	0.00176	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—EGFR—pharynx cancer	0.000766	0.00175	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000755	0.00173	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CCND1—pharynx cancer	0.000752	0.00172	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—B4GALT5—pharynx cancer	0.000752	0.00172	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD79A—pharynx cancer	0.000748	0.00171	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CNDP2—pharynx cancer	0.000724	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00072	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00072	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—EGFR—pharynx cancer	0.00072	0.00165	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—EGFR—pharynx cancer	0.000714	0.00163	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000708	0.00162	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ADH7—pharynx cancer	0.000707	0.00162	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—EGFR—pharynx cancer	0.000704	0.00161	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CNDP2—pharynx cancer	0.000695	0.00159	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000687	0.00157	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000684	0.00157	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000681	0.00156	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000678	0.00155	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—EGFR—pharynx cancer	0.000667	0.00153	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ADH7—pharynx cancer	0.000654	0.0015	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000653	0.0015	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000638	0.00146	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ADH7—pharynx cancer	0.000629	0.00144	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ADH1B—pharynx cancer	0.00062	0.00142	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—EGFR—pharynx cancer	0.000604	0.00138	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—B4GALT5—pharynx cancer	0.000592	0.00136	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—EGFR—pharynx cancer	0.00059	0.00135	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—pharynx cancer	0.000582	0.00133	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000574	0.00131	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—pharynx cancer	0.000572	0.00131	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000569	0.0013	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—pharynx cancer	0.00056	0.00128	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CNDP2—pharynx cancer	0.000552	0.00126	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ADH1B—pharynx cancer	0.000551	0.00126	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000548	0.00126	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.000527	0.00121	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000518	0.00119	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000512	0.00117	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD79A—pharynx cancer	0.0005	0.00115	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—B4GALT5—pharynx cancer	0.000499	0.00114	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ADH7—pharynx cancer	0.000499	0.00114	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—pharynx cancer	0.000495	0.00113	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—EGFR—pharynx cancer	0.000491	0.00112	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000469	0.00107	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDH1—pharynx cancer	0.00046	0.00105	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD79A—pharynx cancer	0.000454	0.00104	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—EGFR—pharynx cancer	0.000445	0.00102	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EGFR—pharynx cancer	0.000438	0.001	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ADH1B—pharynx cancer	0.000438	0.001	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—B4GALT5—pharynx cancer	0.000418	0.000958	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDH1—pharynx cancer	0.000417	0.000954	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000411	0.000942	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000401	0.000919	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000393	0.0009	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EGFR—pharynx cancer	0.000338	0.000773	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000337	0.000772	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EGFR—pharynx cancer	0.00028	0.000641	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDH1—pharynx cancer	0.000279	0.000638	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—EGFR—pharynx cancer	0.000269	0.000615	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EGFR—pharynx cancer	0.000254	0.000581	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDH1—pharynx cancer	0.000253	0.000579	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—EGFR—pharynx cancer	0.000244	0.000558	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—pharynx cancer	0.000163	0.000373	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—pharynx cancer	0.00015	0.000345	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—pharynx cancer	0.000148	0.000339	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—pharynx cancer	0.000134	0.000308	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—pharynx cancer	0.000122	0.000279	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—pharynx cancer	0.000105	0.000241	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—pharynx cancer	9.56e-05	0.000219	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—pharynx cancer	8.91e-05	0.000204	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—pharynx cancer	8.85e-05	0.000203	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—pharynx cancer	8.02e-05	0.000184	CbGpPWpGaD
